ArticleFrontiers in artificial intelligence2025
Enhancing prediction of primary site recurrence in head and neck cancer using radiomics and uncertainty estimation.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NI-RADS in posttreatment head and neck cancer surveillance: a framework for standardized imaging with clinical impact.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Head and neck squamous cell carcinomas (HNSCC) present a significant clinical challenge due to high recurrence rates despite advances in radiation and chemotherapy. Early detection of recurrence is critical for optimizing treatment outcomes and improving patient survival. Methods: We developed two artificial intelligence (AI) pipelines-(1) machine learning models trained on radiomic and clinical data and (2) a Vision Transformer-based model directly applied to imaging data-to predict HNSCC recurrence using pre- and post-treatment PET/CT scans from a cohort of 249 patients. We incorporated Test-Time Augmentation (TTA) and Conformal Prediction to quantify prediction uncertainty and enhance model reliability. Results: The machine learning models achieved an average AUC of 0.820. The vision transformer model showed moderate performance (AUC = 0.658). Uncertainty quantification enabled the exclusion of ambiguous predictions, improving accuracy among more confident cases. Discussion: Our machine learning models achieved strong performance in predicting HNSCC recurrence from radiomic and clinical features. Incorporating uncertainty quantification further improved predictive performance and reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.